Effectiveness of Nefopam in Breast Cancer Surgery
Breast cancer surgery is known to cause severe acute postoperative pain, which can persist for a long time. The investigators administered nefopam preventively to patients undergoing total mastectomy or modified radical mastectomy with axillary lymph node dissection or sentinel lymph node biopsy, and evaluated its efficacy on acute and chronic postoperative pain.
Breast Neoplasm Malignant Primary
DRUG: Nefopam|DRUG: Normal Saline
Change of cumulative analgesia volume infused via intravenous patient-controlled analgesia device, At postoperative 4 hour, 24 hour, 48 hour, 72 hour, 10 day, and 3 month
Change of numerical rating scale for postoperative pain, At postoperative 4 hour, 24 hour, 48 hour, 72 hour, 10 day, and 3 month
Breast cancer surgery is known to cause severe acute postoperative pain, which can persist for a long time. The investigators administered nefopam preventively to patients undergoing total mastectomy or modified radical mastectomy with axillary lymph node dissection or sentinel lymph node biopsy, and evaluated its efficacy on acute and chronic postoperative pain.